- Home
- VRAX vs TGL Comparison
VRAX vs TGL Comparison
Compare VRAX & TGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- TGL
- Stock Information
- Founded
- VRAX 2013
- TGL 2020
- Country
- VRAX United Kingdom
- TGL United States
- Employees
- VRAX N/A
- TGL N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TGL Retail: Computer Software & Peripheral Equipment
- Sector
- VRAX Health Care
- TGL Technology
- Exchange
- VRAX Nasdaq
- TGL Nasdaq
- Market Cap
- VRAX 4.7M
- TGL 3.9M
- IPO Year
- VRAX 2022
- TGL 2022
- Fundamental
- Price
- VRAX $0.81
- TGL $1.05
- Analyst Decision
- VRAX Strong Buy
- TGL
- Analyst Count
- VRAX 1
- TGL 0
- Target Price
- VRAX $3.00
- TGL N/A
- AVG Volume (30 Days)
- VRAX 37.2K
- TGL 2.9M
- Earning Date
- VRAX 02-05-2025
- TGL 08-25-2025
- Dividend Yield
- VRAX N/A
- TGL N/A
- EPS Growth
- VRAX N/A
- TGL N/A
- EPS
- VRAX N/A
- TGL N/A
- Revenue
- VRAX $84,872.00
- TGL $1,468,790.00
- Revenue This Year
- VRAX $5,169.18
- TGL N/A
- Revenue Next Year
- VRAX $66.97
- TGL N/A
- P/E Ratio
- VRAX N/A
- TGL N/A
- Revenue Growth
- VRAX 7.03
- TGL N/A
- 52 Week Low
- VRAX $0.75
- TGL $1.01
- 52 Week High
- VRAX $9.00
- TGL $147.00
- Technical
- Relative Strength Index (RSI)
- VRAX 31.75
- TGL 32.05
- Support Level
- VRAX $0.75
- TGL $1.02
- Resistance Level
- VRAX $0.85
- TGL $1.11
- Average True Range (ATR)
- VRAX 0.07
- TGL 0.10
- MACD
- VRAX -0.01
- TGL 0.02
- Stochastic Oscillator
- VRAX 6.57
- TGL 6.44
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About TGL Treasure Global Inc.
Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.